Fust Matthew K bought CRNX
September 26, 2025 · Form 4 insider transaction
Fust Matthew K bought 10,000 shares of Crinetics Pharmaceuticals Inc at $1.91 per share, a transaction worth $19.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$1.91
Total value
$19.1K
InsiderFust Matthew K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 26, 2025
Filing dateSeptember 30, 2025
Shares owned after38,836
OwnershipDirect
10b5-1 planNo
AmendedNo